Adcytherix logo

Adcytherix jobs and careers

France

About Adcytherix

Adcytherix is a clinical-stage biopharmaceutical company developing novel antibody-drug conjugates (ADCs) for cancer and other serious diseases with high unmet medical need. Its ambition is to become a leading next-generation ADC design company, combining clinically validated targets and innovative payloads derived from approved cancer drugs to deliver differentiated, de-risked therapies driven by patient need. Founded by Jack Elands, CEO, Adcytherix is led by a seasoned team, guided by leading ADC experts, and backed by a top-tier international syndicate of life science investors. Adcytherix is based in Marseille, France, with subsidiaries in the US and the Netherlands.

Founded in 2023 by Carsten Dehning and Jack Elands.

Founded
2023
Employees
11 to 50
Total funding
$30M
Headquarters
France

Leadership

The top of Adcytherix's org chart, with how many people report into each leader.

PJPhoto of Paul Jackson

Paul Jackson

Chief Operating Officer